Citigroup
HURA

Citigroup’s TuHURA Biosciences HURA Stock Holding History

Citigroup’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,937
Closed -$3.47K – 6361
2026
Q1 		$3.47K Buy
1,937
+1,185
+158% +$1.45K ﹤0.01% 5339
2025
Q4 		$569 Sell
752
-929
-55% -$1.78K ﹤0.01% 5579
2025
Q3 		$4.17K Sell
1,681
-7,438
-82% -$19.6K ﹤0.01% 5281
2025
Q2 		$20.3K Buy
+9,119
New +$30.8K ﹤0.01% 5074
2025
Q1 		– Sell
-65,013
Closed -$266K – 6055
2024
Q4 		$266K Buy
+65,013
New +$346K ﹤0.01% 4236
2022
Q2 		– Hold
0
– – – 6746
2022
Q1 		– Hold
0
– – – 6658

Other funds holding HURA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Citigroup's HURA Position: Q2 2026 in Review

Citigroup sold out of TuHURA Biosciences (HURA) in Q2 2026, closing a stake of 1,937 shares — an estimated $3.47K sold.

Citigroup first reported a position in HURA in Q4 2024 and held it in 5 quarters. The position peaked at $266K in Q4 2024. 90 funds tracked by Wall St. Rank hold HURA as of Q2 2026.

  • Citigroup reported no remaining TuHURA Biosciences position as of Q2 2026 after selling out during the quarter.
  • Citigroup sold 1,937 TuHURA Biosciences shares in Q2 2026, an estimated $3.47K.
  • Citigroup first reported a position in TuHURA Biosciences in Q4 2024 and held it in 5 quarters.
  • Citigroup's TuHURA Biosciences position peaked at $266K in Q4 2024.
  • 90 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.